Henry Schein Inc (HSIC)

Currency in USD
78.08
+1.82(+2.39%)
Closed·
76.19-1.89(-2.42%)
·
HSIC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
75.8479.11
52 wk Range
60.5682.49
Key Statistics
Prev. Close
78.08
Open
76.19
Day's Range
75.84-79.11
52 wk Range
60.56-82.49
Volume
1.39M
Average Volume (3m)
1.4M
1-Year Change
8.8223%
Book Value / Share
27.72
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HSIC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
77.64
Downside
-0.56%
Members' Sentiments
Bearish
Bullish
ProTips
6 analysts have revised their earnings downwards for the upcoming period

Henry Schein Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Henry Schein Inc Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Henry Schein Inc Earnings Call Summary for Q3/2025

  • Henry Schein reported Q3 2025 EPS of $1.38 (7.81% above forecast) and revenue of $3.34 billion, driving an 11.72% pre-market stock surge to $69.65
  • Revenue increased 5.2% year-over-year to $3.3 billion, with adjusted EBITDA rising 10% to $295 million amid stable dental and medical markets
  • The company raised its full-year 2025 non-GAAP EPS guidance to $4.88-$4.96, reflecting confidence in ongoing strategic initiatives
  • CEO Stanley Bergman announced restructuring efforts expected to save $100 million annually and deliver over $200 million in operating income improvements
  • Strategic initiatives in AI and digital solutions, alongside share repurchases, are positioned to drive future growth despite potential tariff inflation risks
Last Updated: 2025-11-04, 09:56 a/m
Read Full Transcript

Compare HSIC to Peers and Sector

Metrics to compare
HSIC
Peers
Sector
Relationship
P/E Ratio
23.5x18.7x−0.6x
PEG Ratio
0.750.140.00
Price/Book
2.7x0.9x2.6x
Price / LTM Sales
0.7x0.4x3.4x
Upside (Analyst Target)
2.3%14.6%41.3%
Fair Value Upside
Unlock5.9%4.9%Unlock

Analyst Ratings

6 Buy
9 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 77.64
(-0.56% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy86.00+10.14%-New CoverageDec 09, 2025
Wells Fargo
Hold76.00-2.66%70.00MaintainNov 05, 2025
JPMorgan
Buy78.00-0.10%76.00MaintainNov 05, 2025
Morgan Stanley
Sell58.00-25.72%55.00MaintainNov 05, 2025
Baird
Hold78.00-0.10%72.00MaintainNov 05, 2025

Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
1.38 / 1.28
Revenue / Forecast
3.34B / 3.28B
EPS Revisions
Last 90 days

HSIC Income Statement

People Also Watch

69.96
TECH
+2.28%
163.76
EXPD
+0.95%
62.17
ROL
+0.02%
82.31
COO
+0.76%
175.33
CHRW
+1.75%

FAQ

What Is the Henry Schein (HSIC) Stock Price Today?

The Henry Schein stock price today is 78.08

What Stock Exchange Does Henry Schein Trade On?

Henry Schein is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Henry Schein?

The stock symbol for Henry Schein is "HSIC."

What Is the Henry Schein Market Cap?

As of today, Henry Schein market cap is 9.19B.

What Is Henry Schein's Earnings Per Share (TTM)?

The Henry Schein EPS (TTM) is 3.17.

When Is the Next Henry Schein Earnings Date?

Henry Schein will release its next earnings report on Feb 18, 2026.

From a Technical Analysis Perspective, Is HSIC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Henry Schein Stock Split?

Henry Schein has split 2 times.

How Many Employees Does Henry Schein Have?

Henry Schein has 25000 employees.

What is the current trading status of Henry Schein (HSIC)?

As of Jan 16, 2026, Henry Schein (HSIC) is trading at a price of 78.08, with a previous close of 78.08. The stock has fluctuated within a day range of 75.84 to 79.11, while its 52-week range spans from 60.56 to 82.49.

What Is Henry Schein (HSIC) Price Target According to Analysts?

The average 12-month price target for Henry Schein is USD77.64286, with a high estimate of USD90 and a low estimate of USD58. 6 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -0.56% Downside potential.

What Is the HSIC After Hours Price?

HSIC's last after hours stock price is 76.19, the stock has decreased by -1.89, or -2.42%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.